Cozad Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,791
Closed -$362K 381
2022
Q4
$362K Buy
1,791
+62
+4% +$12.1K 0.05% 272
2022
Q3
$304K Hold
1,729
0.05% 273
2022
Q2
$348K Hold
1,729
0.05% 265
2022
Q1
$392K Hold
1,729
0.05% 260
2021
Q4
$467K Hold
1,729
0.07% 229
2021
Q3
$418K Hold
1,729
0.07% 238
2021
Q2
$410K Sell
1,729
-58
-3% -$13.2K 0.06% 236
2021
Q1
$391K Hold
1,787
0.06% 243
2020
Q4
$312K Hold
1,787
0.06% 254
2020
Q3
$289K Hold
1,787
0.05% 257
2020
Q2
$255K Buy
+1,787
New +$247K 0.05% 271
2020
Q1
Sell
-1,845
Closed -$268K 230
2019
Q4
$268K Hold
1,845
0.07% 208
2019
Q3
$266K Hold
1,845
0.08% 208
2019
Q2
$274K Hold
1,845
0.08% 199
2019
Q1
$242K Sell
1,845
-111
-6% -$13.7K 0.07% 211
2018
Q4
$212K Buy
+1,956
New +$262K 0.07% 216

Other funds holding LH

Cozad Asset Management's LH Position: Q1 2023 in Review

Cozad Asset Management sold out of Labcorp (LH) in Q1 2023, closing a stake of 1,791 shares — an estimated $362K sold.

Cozad Asset Management first reported a position in LH in Q4 2018 and held it in 16 quarters. The position peaked at $467K in Q4 2021. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

  • Cozad Asset Management reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
  • Cozad Asset Management sold 1,791 Labcorp shares in Q1 2023, an estimated $362K.
  • Cozad Asset Management first reported a position in Labcorp in Q4 2018 and held it in 16 quarters.
  • Cozad Asset Management's Labcorp position peaked at $467K in Q4 2021.
  • 940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Cozad Asset Management's 13F filing for Q1 2023, filed 1 May 2023.